ArticleThe FEBS journal2026
Aquaporin-1, aquaporin-3 and aquaporin-5 differentially modulate cell biophysical and biomechanical properties, impacting cell stiffness and cell-cell adhesion.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids.FEBS open bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aquaporins (AQPs) are transmembrane proteins that facilitate the movement of water, glycerol, and other small solutes across cell membranes. AQP1, AQP3, and AQP5 are overexpressed in cancer, contributing to cancer cell proliferation, migration, angiogenesis, and metastasis. Previously, we showed that silencing AQP3 and/or AQP5 in human pancreatic ductal adenocarcinoma cells induced morphological changes and decreased cell-cell adhesion, with AQP5 modulating cell stiffness and membrane fluidity, suggesting that AQPs can impact tumor progression via modulation of cell biophysical and biomechanical properties. In this study, we overexpressed AQP1, AQP3, or AQP5 individually in human kidney (HEK-293 T) cells to investigate their individual effects on biological processes, cell morphology, and biomechanical features. After validating AQP expression and function, we evaluated their impact on cell proliferation and migration. Although cell proliferation remained unaffected, AQP5 overexpression enhanced cell migration. Afterwards, we assessed the effect of these AQPs on cell morphological properties through atomic force microscopy (AFM) imaging. AQP1-, AQP3-, and AQP5-overexpressing cells showed no significant changes in cell morphology. AFM-based force spectroscopy demonstrated that AQP1 overexpression increased both cell stiffness and cell-cell adhesion, AQP3 overexpression enhanced cell stiffness but slightly reduced cell-cell adhesion, whereas AQP5 overexpression increased both cell elasticity and cell-cell adhesion. Thus, AQP1, AQP3, and AQP5 may play a crucial role in promoting tumor growth and invasion by differentially modulating cell stiffness and cell-cell adhesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.